TITLE

Trental® 400 in the Treatment of Intermittent Claudication: Results of Long-Term, Placebo-Controlled Administration

AUTHOR(S)
Roekaerts, F.; Deleers, L.
PUB. DATE
July 1984
SOURCE
Angiology;Jul1984, Vol. 35 Issue 7, p396
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
A double-blind, randomized, placebo-controlled long-term clinical study of Trental® 400 was carried out, partly under cross-over design, partly as a parallel-group study, in 36 patients suffering from chronic arterial obstructive disorders in the lower limbs, associated with intermittent claudication, in order to evaluate the effectiveness and the safety of this drug administered t.i.d. over a period of 6 months. This controlled period was preceded by a placebo run-in period of 3 months. The clinical results under Trental 400 showed a statistically significant within group improvement of painfree and maximum walking parameters (p < 0.05) corresponding to an increase to baseline by +96% to +139% respectively and also in comparison to placebo (p < 0.05). The alterations of walking parameters within the placebo groups, ranging between -25% and +28% were not significant. The subjective parameters (rest pain, paraesthesias, muscular cramps and sensation of heaviness in the legs) paralleled the course of the walking parameters. Under Trental 400, 24 out of 36 patients reported an improvement of these symptoms compared to 7 under placebo. Trental 400 was well tolerated. Minor side effects were mentioned by 7 out of 36 patients. One patient had to stop the drug treatment because of persisting prickling sensation and subsequent insomnia. Drug-related changes in the laboratory findings could not be detected; vital signs varied in function of age, concomitant drug treatments and seasonal factors. The results obtained in these studies suggest Trental 400 as a drug of choice for treating patients with intermittent claudication due to peripheral ar- terial obstruction according to stage II or III after Fontaine.
ACCESSION #
16352700

 

Related Articles

  • The Effectiveness of Isoxsuprine in Patients With Intermittent Claudication. Skotnicki, S. H.; van Gaal, G.; Wijn, P. F. F. // Angiology;Nov1984, Vol. 35 Issue 11, p685 

    Sixty male patients with intermittent claudication were investigated in a randomized, double-blind, placebo-controlled study in order to determine the effectiveness of Isoxsuprine. The analysis of the results was made on the basis of subjective assessment of symptoms by the patients themselves...

  • Silence of the Limbs: Pharmacological Symptomatic Treatment of Intermittent Claudication. De Backer, Tine; Vander Stichele, Robert; De Buyzere, Marc; De Backer, Guy; Van Bortel, Lucas // Current Vascular Pharmacology;May2010, Vol. 8 Issue 3, p383 

    Several oral "vasoactive" drugs claim to increase walking capacity in patients with intermittent claudication (IC). Naftidrofuryl, cilostazol, buflomedil, and pentoxifylline are the most studied molecules. Although spanning several decades, several studies underlying these claims were not...

  • Evaluation of Skeletal Muscle Metabolic Responses Following Exercise Training in Patients with... Back, Martin R.; Kluess, Heidi A.; Huber, Thomas S.; Stopka, Christine B.; Scott, Katherine N.; Ballinger, J. Raymond; Welsch, Michael A.; Bruner, Angela P.; Lyles, Teresa; Harward, Timothy R.S.; Seeger, James M. // Vascular Surgery;Jul/Aug2000, Vol. 34 Issue 4, p345 

    Examines factors responsible for the exercise intolerance occurring in patients with peripheral arterial occlusive disease (PAOD) manifesting intermittent claudication (IC) and contributing to the observed improvements in walking capacity. Characterization of the resting and exercise response...

  • Bencyklan -- zastosowania kliniczne. Tomkowski, Witold Z. // Acta Angiologica;2013, Vol. 19 Issue 2, p65 

    Article is addressed to clinical applications of bencyclane based on clinical trials.

  • Pentoxifylline in the Treatment of Intermittent Claudication of the Lower Limbs. Reich, Theobald; Cutler, Bruce C.; Lee, Bok Y.; Porter, John M.; Reichle, Frederick A.; Scogin, John T.; Strandness, D. Eugene // Angiology;Jul1984, Vol. 35 Issue 7, p389 

    Pentoxifylline, a methyl xanthine analogue was evaluated for treatment of intermittent claudication in a double-blind placebo controlled parallel group study in seven centers in the United States. Tests were performed on 128 cases, including 42 who took pentoxifylline (600 mg by mouth daily,...

  • Placebo-Controlled Trial of Ketanserin in the Treatment of Intermittent Claudication. Cameron, H. A.; Waller, P. C.; Ramsay, L. E. // Angiology;Jul1987, Vol. 38 Issue 7, p549 

    The effect of ketanserin on the symptoms of 21 patients with stable intermittent claudication was examined in a double-blind, placebo-controlled, parallel-group study. Benefit was assessed by repeated treadmill exercise tests, recording claudication and total walking times. After three months'...

  • Optimal assessment of baseline treadmill walking performance in claudication clinical trials. Brass, Eric P.; Jiao, Jenny; Hiatt, William // Vascular Medicine;2007, Vol. 12 Issue 2, p97 

    Treadmill testing is frequently used to assess the functional capacity of patients with claudication, but the optimal application of treadmill testing in the setting of multicenter clinical trials remains uncertain. The current study used data from a recent clinical trial of the drug NM-702,...

  • Beneficial Effects of Intermittent Suction and Pressure Treatment in Intermittent Claudication. Mehlsen, Jesper; Himmelstrup, Holger; Himmelstrup, Bodil; Winther, Kaj; Trap-Jensen, Jens // Angiology;Jan1993 Supplement, Vol. 44, p16 

    The present study reports on the effects of a physical treatment modality in patients with intermittent claudication. During this treatment a major part of the skin surface is subjected to intermittent suction and pressure. In a previous, preliminary study the authors found a beneficial effect...

  • PARADOXICAL EFFECT ON PERIPHERAL BLOOD FLOW AFTER SYMPATHETIC BLOCKADES IN PATIENTS WITH GANGRENE DUE TO ARTERIOSCLEROSIS OBLITERANS. Uhrenholdt, A.; Dam, W. H.; Larsen, O. Andree; Lassen, N. A. // Vascular Surgery;May/Jun1971, Vol. 5 Issue 3, p154 

    A total of 61 lumbar sympathetic blockades were performed on 5 patients with gangrene on one or several toes and on 6 patients with intermittent claudication only. Subcutaneons blood flow on the dorsum of the foot was measured by the Xenon clearance technique before and after the blockades. In...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics